InvestorsHub Logo
Followers 3
Posts 964
Boards Moderated 0
Alias Born 03/30/2021

Re: TexasMarvL post# 5211

Wednesday, 04/17/2024 1:12:31 AM

Wednesday, April 17, 2024 1:12:31 AM

Post# of 5329
QuickVue® Adenoviral Conjunctivitis Test by Quidel is also listed for sale on the Verséa Ophthalmics website.

Verséa Ophthalmics is building their business.
The AXIM tests are a focal point but not the only line of revenue.

Why has Verséa Ophthalmics been so quiet on LinkedIn recently?

I have to believe the TPOC Tear-based Parkinson Disease Point-of-Care test is a really big deal for Verséa to have exclusive merchandising rights to. In my opinion the marketing agreement for the Parkinson Disease test can bring upfront cash and also revenue $ per test sold.

My guess is the Parkinson Disease test would not be limited to eyecare locations.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXIM News